Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
772
-
Total 13F shares, excl. options
-
94.4M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$16.9B
-
Value change
-
+$251M
-
Put/Call ratio
-
0.41
-
Number of buys
-
330
-
Number of sells
-
-352
-
Price
-
$179.53
Significant Holders of Labcorp Hldgs Inc. - COM (LH) as of Q2 2018
854 filings reported holding LH - Labcorp Hldgs Inc. - COM as of Q2 2018.
Labcorp Hldgs Inc. - COM (LH) has 772 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.7M shares), BlackRock Inc. (8.71M shares), Boston Partners (5.67M shares), STATE STREET CORP (4.05M shares), AMUNDI PIONEER ASSET MANAGEMENT INC (2.13M shares), NORDEA INVESTMENT MANAGEMENT AB (2.05M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.76M shares), OppenheimerFunds, Inc. (1.7M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.65M shares), and JPMORGAN CHASE & CO (1.43M shares).
This table shows the top 772 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.